Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Weight Loss 1Ovarian Neoplasms 1Osteochondroma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Nevus, Epithelioid and Spindle Cell 1Malnutrition 1Lung Neoplasms 1Hematologic Neoplasms 1Glioblastoma 1Giant Cell Tumors 1Gastrointestinal Neoplasms 1Fibrosis 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Lobular 1Carcinoma in Situ 1Barrett Esophagus 1

Interventions

Fulvestrant 3Carboplatin 2repotrectinib 1neratinib 1Vorinostat 1Trastuzumab 1Taxes 1Sampling Studies 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Adjuvant 1Radiotherapy 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Mastectomy, Segmental 1Mass Spectrometry 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Immunohistochemistry 1High-Energy Shock Waves 1Gene Expression Profiling 1Fluorescent Antibody Technique 1Drugs, Generic 1Drug Therapy 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Crizotinib 1Chromatography, Liquid 1Blood Specimen Collection 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Lobular × Sampling Studies × 1 year × Clear all
NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Dana-Farber Cancer Institute

Recruiting
5,000 enrolled
GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡